Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma - Related Videos
05:22
Intraoperative Strategy under Complex Vascular Adhesion for Laparoscopic Radical Resection of Bismuth-Corlette Type IIIb Perihilar Cholangiocarcinoma
0 Views •
2026
The protocol presents a step-by-step laparoscopic protocol for radical resection of Bismuth-Corlette type IIIb perihilar cholangiocarcinoma. The procedure integrates preoperative PTCD, complex vascular dissection and repair, and biliary reconstruction for application in high-volume hepatobiliary centers.
03:45
Right Hemihepatectomy by Suprahilar Intrahepatic Transection of the Right Hemipedicle using a Vascular Stapler
0 Views •
Cited by 1 •
2010
This video describes a right hemihepatectomy with intrahepatic transection of the right hemipedicle leaving the hepatoduodenal ligament completely untouched.
10:35
Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
0 Views •
Cited by 15 •
2013
Human tumor xenografts in immunodeficient mice are valuable tools to study cancer biology. Specific protocols to generate subcutaneous and intrahepatic xenografts from human hepatocellular carcinoma cells or tumor fragments are described. Liver regeneration induced by partial hepatectomy in recipient mice is presented as a strategy to facilitate intrahepatic engraftment.
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
0 Views •
2025
Perihilar cholangiocarcinoma (pCCA) is a highly malignant and aggressive tumor, with radical resection being the only curative treatment available. With continuous advancements in laparoscopic techniques and instruments, laparoscopic radical surgery for pCCA is now considered technically safe and feasible. However, due to the high complexity of the surgery and the lack of evidence-based clinical support, laparoscopic radical surgery for type IIIb pCCA is performed only in a few large...
07:55
The Influence of Liver Resection on Intrahepatic Tumor Growth
0 Views •
Cited by 6 •
2016
A high incidence of tumor recurrence after resection of liver metastases remains an unsolved problem. The illustrated mouse model may be useful to investigate the reasons for such recurrences. It combines a liver resection model with intrahepatic tumor cell injection for the first time.
FAQs
Genetic and epigenetic alterations disrupt the normal regulation of biliary cell growth, survival, and differentiation. These changes can shift cells toward uncontrolled expansion and abnormal persistence, creating a biological basis for tumor development. Their combined effects also help explain why the disease can become invasive and why molecular profiling contributes to diagnosis and treatment selection.
As the tumor invades hepatic tissue, it may obstruct the normal flow of bile through the intrahepatic ducts. This local effect reflects both the tumor’s anatomic origin and its destructive growth pattern. Invasion also permits spread through the liver, making the extent of tissue involvement important for staging and for determining whether localized treatment remains appropriate.
Molecular profiling examines the genetic and epigenetic features associated with the tumor rather than relying only on its appearance. Used alongside clinical assessment, imaging, and histopathology, it helps characterize the disease and supports treatment selection. Its value is especially relevant when clinicians must distinguish tumor biology and potential therapeutic direction in advanced disease.
Distinguishing this cancer from hepatocellular carcinoma and metastatic disease requires multiple forms of evidence. Clinical assessment establishes the medical context, imaging evaluates the lesion and liver involvement, and histopathology examines tumor features. Molecular profiling can add biological information. Combining these approaches reduces reliance on a single finding and supports more accurate diagnosis and staging.
Evaluation combines clinical assessment with imaging, histopathology, and molecular profiling. These methods contribute different information: clinical findings provide context, imaging shows the tumor and its distribution, histopathology supports tumor classification, and molecular profiling characterizes relevant biology. Together, they establish the diagnosis, help distinguish competing diagnoses, and provide information needed for staging and treatment planning.
Treatment selection depends substantially on whether the tumor is localized or advanced. Surgery is used for localized tumors, whereas systemic or targeted therapies are considered for advanced disease. Staging connects diagnostic findings with this decision by describing the extent of involvement. In medicine, this approach aligns treatment intensity with the tumor’s distribution and biological information.